Immunological characteristics and effect of cyclosporin in patients with immune thrombocytopenia.

Ting WangXin HeNingyuan RanChunyan LiuLimin XingHuaquan WangWenhui LeiZonghong Shao

Published in: Journal of clinical laboratory analysis (2021)

ITP is a heterogeneous disease, recurrence may occur during or rapidly after treatment. Cyclosporine included treatment can improve the effective rate of ITP and reduce the relapse rate within 3 months. The number of CD3+T lymphocytes was the only impact factor that influence the therapeutic effect of cyclosporin in ITP patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
free survival
prognostic factors
patient reported outcomes
patient reported
nk cells